Thema: US52490G1022
LEGN, US52490G1022
don-3565699_1920.jpg - Foto: THN
Legend Biotech stock holds at EUR 19.75 in late Berlin trading
Legend Biotech stock was unchanged in a late-session snapshot dated October 29. The report focuses on trading data and records the bid and ask alongside the quoted price.
ad-hoc-news.de, heute 01:12 Uhr
LEGN, US52490G1022
Legend Biotech stock: FDA clears LB2501. What it means for ...
FDA cleared LB2501 on October 15, 2026 for a Phase 1/2 study. Legend Biotech stock posted revenue of USD 387.50 million, up 51.90 percent year over year.
ad-hoc-news.de, 23.10.26 04:48 Uhr
LEGN, US52490G1022
JPMorgan cuts target for Legend Biotech stock to USD 33
Second-quarter revenue reached USD 387.50 million, up 51.90 percent year over year. Legend Biotech stock costs EUR 16.90 on October 20, 2026.
ad-hoc-news.de, 20.10.26 19:04 Uhr
LEGN, US52490G1022
H.C. Wainwright keeps USD 65.00 target for Legend Biotech ...
Thirteen analysts set a USD 45.62 average target on October 14, 2026. Legend Biotech stock costs USD 18.48 on October 16, down 6.67 percent on Nasdaq.
ad-hoc-news.de, 17.10.26 18:47 Uhr
LEGN, US52490G1022
Legend Biotech stock rises to EUR 17.60 up 3.68 percent ...
Revenue was USD 387.50 million in second-quarter 2026. Legend Biotech stock costs EUR 17.60 on October 15, 2026, up 3.68 percent on Nasdaq.
ad-hoc-news.de, 15.10.26 20:59 Uhr
LEGN, US52490G1022
Legend Biotech presents CARVYKTI data and LEGN stock fell ...
CARVYKTI kept 50.00 percent progression-free at five years. LEGN stock last traded at EUR 16.50 on October 2, 2026, versus EUR 17.20, down 4.07 percent.
ad-hoc-news.de, 07.10.26 00:54 Uhr
LEGN, US52490G1022
Legend Biotech stock gained 1.10 percent on October 5
Legend Biotech stock posted Q2 revenue of USD 387.5 million on August 11, 2026, up 51.9 percent year over year. Five-year CARVYKTI data showed 69.2 percent survival.
ad-hoc-news.de, 06.10.26 12:49 Uhr
LEGN, US52490G1022
Legend Biotech stock reports Q2 profit as target stays at ...
Legend Biotech stock closed at USD 19.11 on September 25, 2026, while H.C. Wainwright kept a USD 65.00 target. Q2 revenue rose 51.9 percent year over year.
ad-hoc-news.de, 28.09.26 23:13 Uhr
LEGN, US52490G1022
Legend Biotech stock gains after strong quarterly figures ...
Legend Biotech stock closed at USD 17.61 on September 18, 2026, up 0.17 percent. CARVYKTI data remain the key operating reference.
ad-hoc-news.de, 22.09.26 07:47 Uhr
